State Street SPDR S&P Biotech ETF ($XBI) Insider Trading & Smart Money Activity

State Street SPDR S&P Biotech ETF · Latest filing Oct 16, 2026

State Street SPDR S&P Biotech ETF ($XBI) has 3 13F position changes on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

3

Analyst ratings on file

0

XBI insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	2 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All XBI insider, congress, 13F and analyst activity

All 13F

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 16, 2026	13F	PFG Advisors	New	+11.48K sh	$1.81M						Read
Oct 16, 2026	13F	Banque Pictet & Cie	Reduced	-37.05K sh	$2.64M						—
Oct 15, 2026	13F	Mirae Asset Securities (Usa)	Added	+150.67K sh	$39.53M						—

1W / 1M / 6M = how XBI moved from the trade or filing date.

Institutions moving XBI (13F)

• PFG Advisors1
• Banque Pictet & Cie1
• Mirae Asset Securities (Usa)1

Frequently asked questions

Which institutions changed their XBI positions?

Recent 13F filers moving the stock include PFG Advisors, Banque Pictet & Cie and Mirae Asset Securities (Usa).

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.